Company Filing History:
Years Active: 2018
Title: Karamatullah Danyal: Innovator in Asthma Treatment
Introduction
Karamatullah Danyal is a notable inventor based in South Burlington, Vermont. He has made significant contributions to the field of medical science, particularly in the development of treatments for asthma and related conditions. His innovative work focuses on the use of covalent inhibitors to target specific enzymes involved in respiratory diseases.
Latest Patents
Danyal holds a patent for "Covalent inhibitors of dual oxidase 1 (DUOX 1)." This invention relates to inhibitors that can be applied to subjects who have or are at risk for asthma. The patent outlines various methods of application, including pulmonary or topical delivery. The inhibitors may include peptides or other moieties with reactive electrophiles that target cysteine or other residues within DUOX1 to inhibit its activity. Notable examples of suitable inhibitors mentioned in the patent include hydroxynonenal, curcumin, sulforaphane, cinnamaldehyde, dimethyl fumarate, and phenyl vinyl sulfonate.
Career Highlights
Karamatullah Danyal is affiliated with the University of Vermont and State Agricultural College, where he conducts research and develops innovative solutions for health-related challenges. His work has the potential to improve the quality of life for individuals suffering from asthma and similar conditions.
Collaborations
Danyal has collaborated with esteemed colleagues such as Albert Van Der Vliet and David Earl Heppner. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Karamatullah Danyal is a pioneering inventor whose work in developing covalent inhibitors for asthma treatment showcases his commitment to improving healthcare. His contributions to medical science are invaluable and hold promise for future advancements in respiratory health.